Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Green Fresh Biotechnology CoHKSE:01084 -6.43%52 Current Ratio is 1.68 as of Dec. 2025, which is 15% above its 10-year median of 1.46. GuruFocus rates HKSE:01084 with a GF Score™ of 52/100 and a GF Value™ of HK$0.55 (Modestly Overvalued). The stock has 10 warning signs investors should review. Among 1,990 Consumer Packaged Goods companies, Green Fresh Biotechnology Co ranks worse than 51.71% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Green Fresh Biotechnology Co's current ratio for the quarter that ended in Dec. 2025 was 1.68.
Green Fresh Biotechnology Co has a current ratio of 1.68. It generally indicates good short-term financial strength.
The historical rank and industry rank for Green Fresh Biotechnology Co's Current Ratio or its related term are showing as below:
HKSE:01084'
s Current Ratio Range Over the Past 10 Years
Min: 0.79 Med: 1.46 Max: 1.74
Current: 1.68
During the past 10 years, Green Fresh Biotechnology Co's highest Current Ratio was 1.74. The lowest was 0.79. And the median was 1.46.
HKSE:01084's Current Ratio is ranked worse than 51.71% of 1990
companies
in the Consumer Packaged Goods industry
Industry Median: 1.72
vs HKSE:01084: 1.68
Green Fresh Biotechnology Co (HKSE:01084) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Green Fresh Biotechnology Co Current Ratio Related Terms
Green Fresh Biotechnology Co Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01084 vs ADM, BG, TSN: Current Ratio Comparison
For the Farm Products subindustry, Green Fresh Biotechnology Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Green Fresh Biotechnology Co Current Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Green Fresh Biotechnology Co's Current Ratio distribution charts can be found below:
* The bar in red indicates where Green Fresh Biotechnology Co's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Fresh Biotechnology Co (HKSE:01084) has a Current Ratio of 1.68 as of Dec. 2025. This is 15% above median its historical median of 1.46. Over the past decade, Green Fresh Biotechnology Co's Current Ratio has ranged from 0.79 to 1.74. According to the industry distribution chart, Green Fresh Biotechnology Co ranks #1029 out of 1990 companies in the Consumer Packaged Goods industry, placing it in the top 51.7%.
Is Green Fresh Biotechnology Co's Current Ratio too high?
Green Fresh Biotechnology Co's current Current Ratio of 1.68 is 15% above median its 10-year median of 1.46. Over the past 10 years, this metric has ranged from a low of 0.79 to a high of 1.74. The Consumer Packaged Goods industry median Current Ratio is 1.72. Green Fresh Biotechnology Co's value of 1.68 is 2.3% below this industry median. Based on the distribution chart, Green Fresh Biotechnology Co ranks #1029 out of 1990 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Green Fresh Biotechnology Co has a GF Score™ of 52/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Green Fresh Biotechnology Co's Current Ratio compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Green Fresh Biotechnology Co ranks #1029 out of 1990 companies for Current Ratio. This places Green Fresh Biotechnology Co in the lower half of its industry. The industry median Current Ratio is 1.72. Green Fresh Biotechnology Co's value of 1.68 is 2.3% below this benchmark. Historically, Green Fresh Biotechnology Co's own Current Ratio has ranged from 0.79 to 1.74 over the past decade. While the company's 10-year median is 1.46 vs. the industry median of 1.72, Green Fresh Biotechnology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Consumer Packaged Goods company?
The median Current Ratio among Consumer Packaged Goods companies is 1.72, based on 1,990 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Green Fresh Biotechnology Co's current Current Ratio of 1.68 is 2.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median Current Ratio is 1.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Green Fresh Biotechnology Co's current Current Ratio is 1.68, which is 15% above median its own 10-year median of 1.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Fresh Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Green Fresh Biotechnology Co (HKSE:01084) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$0.55, compared to a current price of HK$0.66 — trading 19.1% above its estimated fair value. The current Current Ratio is 1.68, which is 15% above median its 10-year median of 1.46 and 2.3% below the Consumer Packaged Goods industry median of 1.72. Green Fresh Biotechnology Co's overall GF Score™ is 52/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Green Fresh Biotechnology Co (HKSE:01084), the current Current Ratio is 1.68 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Green Fresh Biotechnology Co (HKSE:01084) Overvalued in 2026?
Based on GuruFocus' analysis, Green Fresh Biotechnology Co stock appears to be overvalued.
The current stock price of HK$0.66 is trading 19.1% above its estimated GF Value™ of HK$0.55.
GuruFocus considers Green Fresh Biotechnology Co to be Modestly Overvalued.
Key valuation signals for HKSE:01084:
Current Ratio: 1.68 (15% above median its 10-year median of 1.46)
GF Value™: HK$0.55 vs. price of HK$0.66 (19.1% above fair value)
Industry Position: 2.3% below the Consumer Packaged Goods median (#1029 of 1990)
No single metric tells the full story. See the HKSE:01084 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Green Fresh Biotechnology Co Ltd, formerly Green Future Food Hydrocolloid Marine Science Co Ltd is engaged in manufacturing and sales of food manufacturing hydrocolloid products including carrageenan products, agar-agar products, blended products, and konjac products in the People's Republic of China and overseas. Its segments include Manufacturing and sales of agar-agar products, which derives maximum revenue; Manufacturing and sales of carrageenan; Manufacturing and sales of konjac products; Manufacturing and sales of blended products; and Others, such as trading of seaweed powder and other operations. Its operations are spread across Chinese Mainland, which derives maximum revenue; Europe; Asia (excluding Chinese Mainland); South America; North America; Africa; and Oceania.
52GF Score
Get the complete analysis for HKSE:01084
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01084 has been successfully added to your 
